Grants and Contributions:
Title:
Development of cell lines for enzyme production, scale-up and purification
Agreement Number:
974580
Agreement Value:
$45,000.00
Agreement Date:
Jun 16, 2021 - Jun 30, 2022
Description:
The project will involve the development of standard operating procedures (SOP) for expression, scale up production and purification of 0.5 gram level quantity of two types blood type converting enzymes meeting Good Laboratory Practices (GLP) standards.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V7X 1L3
Reference Number:
172-2021-2022-Q2-974580
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
706842473
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 197 days. The total amended value is 24,000 dollars.
Amendment Date
Dec 18, 2021
Recipient's Legal Name:
ABOzymes Biomedical Inc.
Federal Riding Name:
Vancouver Centre
Federal Riding Number:
59034
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: